Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherHighlighted Papers

Magnesium Modifies the Impact of Calcitriol Treatment In Chronic Kidney Disease

Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 351; DOI: https://doi.org/10.1124/jpet.115.1215HIa
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Chronic kidney disease (CKD) patients are commonly treated with vitamin D analogs, such as calcitriol. Recent epidemiological evidence revealed a significant interaction between vitamin D and magnesium, suggesting that increased magnesium improved mortality. The aim of the present study was to assess the mechanisms involved by determining whether magnesium combined with calcitriol treatments had an impact on vascular calcification (VC) in male Sprague-Dawley rats with adenine-induced CKD. Given alone, calcitriol increased the prevalence of VC; but when magnesium was given in combination, the severity of calcification was attenuated in the abdominal aorta, iliac and carotid arteries. The decreases in vascular calcium content were associated with an increase in vascular Mg. Calcitriol treatment alone significantly decreased TRPM7 protein whereas the combination treatment increased both the mRNA and protein expression. These findings suggest that modifying the adverse effect profile of calcitriol with Mg may be a plausible approach to benefiting CKD patients prescribed calcitriol.

See article at J Pharmacol Exp Ther 2015 355:451–462.

  • Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 355 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 355, Issue 3
1 Dec 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Magnesium Modifies the Impact of Calcitriol Treatment In Chronic Kidney Disease
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherHighlighted Papers

Magnesium Modifies the Impact of Calcitriol Treatment In Chronic Kidney Disease

Journal of Pharmacology and Experimental Therapeutics December 1, 2015, 355 (3) 351; DOI: https://doi.org/10.1124/jpet.115.1215HIa

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherHighlighted Papers

Magnesium Modifies the Impact of Calcitriol Treatment In Chronic Kidney Disease

Journal of Pharmacology and Experimental Therapeutics December 1, 2015, 355 (3) 351; DOI: https://doi.org/10.1124/jpet.115.1215HIa
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Directly Observable Behavioral Effects of Lorcaserin in Rats
  • Minimal Anticipated Biological Effect Level of Anti-CD28 Receptor Antagonist
Show more HIGHLIGHTED PAPERS

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics